Tue, November 23, 2021
Mon, November 22, 2021
Sun, November 21, 2021
Sat, November 20, 2021
Fri, November 19, 2021

Tiago Fauth Maintained (BMRN) at Buy with Increased Target to $105 on, Nov 22nd, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-105-on-nov-22nd-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Tiago Fauth of Credit Suisse, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $100 to $105 on, Nov 22nd, 2021.

Tiago has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 1 agrees with Tiago's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kennen MacKay of "RBC Capital" Maintained at Hold with Increased Target to $88 on, Thursday, July 29th, 2021


This is the rating of the analyst that currently disagrees with Tiago


  • Paul Matteis of "Stifel" Upgraded from Hold to Strong Buy and Increased Target to $96 on, Thursday, September 9th, 2021